ISLET AMYLOID POLYPEPTIDE - DOES IT PLAY A PATHOPHYSIOLOGICAL ROLE IN THE DEVELOPMENT OF DIABETES

被引：9

作者：

BENNETT, WM ^{[1
]}

SMITH, DM ^{[1
]}

BLOOM, SR ^{[1
]}

机构：

[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,DU CANE RD,LONDON W12 0NN,ENGLAND

来源：

DIABETIC MEDICINE | 1994年 / 11卷 / 09期

关键词：

ISLET AMYLOID POLYPEPTIDE; TYPE; 2; DIABETES; PATHOGENESIS; PANCREAS;

D O I：

10.1111/j.1464-5491.1994.tb00363.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is suggestive evidence that amylin acts physiologically in an autocrine manner within the islet to restrain insulin secretion, but conversely there is little indication that this action of amylin plays any role in the development of NIDDM. Deposition of amylin within pancreatic islets is a feature in patients with NIDDM but is of sufficient degree to disrupt beta-cell function in only a small minority of individuals. Current evidence suggests that amylin does not have any physiologically important extra-islet metabolic effects. The potential exists for the development of amylin antagonists as pharmacological agents to enhance insulin secretion in NIDDM but antagonism of systemic CGRP would need to be avoided. There is little, if any, indication that either replacement of amylin or treatment with amylin agonists are likely to have any beneficial role in patients with IDDM.

引用

页码：825 / 829

页数：5

共 61 条

[41]

Ohsawa H., Hanatsuka A., Yamaguchi T., Makino T., Yoshida S., Islet amyloid polypeptide inhibits glucose‐stimulated insulin secretion in isolated rat pancreatic islets, Biochem Biophys Res Commun, 160, pp. 961-967, (1989)

[42]

Ar'Rajab A., Ahren B., Effects of amidated rat islet amyloid polypeptide on glucose‐stimulated insulin secretion in vivo and in vitro in rats, Eur J Pharmacol, 192, pp. 443-445, (1991)

[43]

Nagamatsu S., Carroll RJ, Grodsky GM, Steiner DF, Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets, Diabetes, 39, pp. 871-874, (1990)

[44]

Silvestre RA, Peiro E., Degano P., Miralles P., Marco J., Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas, Regul Pept, 31, pp. 23-31, (1990)

[45]

Peiro E., Degano P., Silvestre RA, Marco J., Inhibition of insulin release by amylin is not mediated by changes in somatostatin output, Life Sci, 49, pp. 761-765, (1991)

[46]

Kogire M., Ishizuka J., Thompson JC, Greeley GH, Inhibitory action of islet amyloid polypeptide and calcitonin gene‐related peptide on release of insulin from the isolated perfused rat pancreas, Pancreas, 6, pp. 459-463, (1991)

[47]

Degano P., Silvestre RA, Salas M., Peiro E., Marco J., Amylin inhibits glucose‐induced insulin secretion in a dose dependent‐manner. Study in the perfused rat pancreas, Regul Pept, 43, pp. 91-96, (1993)

[48]

Bretherton-Watt D., Gilbey SG, Ghatei MA, Beacham J., MacRae AD, Bloom SR, Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man, J Clin Endocrinol Metab, 74, pp. 1032-1035, (1992)

[49]

Wagoner PK, Chen C., Worley JF, Dukes ID, Oxford GS, Amylin modulates b̃‐cell glucose sensing via effects on stimulus‐secretion coupling, Proc Natl Acad Sci USA, 90, pp. 9145-9149, (1993)

[50]

Bennet WM, Beis CS, Ghatei MA, Byfield PG, Bloom SR, Amylin tonally regulates arginine‐stimulated insulin secretion in rat, Diabetologia, (1994)

← 1 2 3 4 5 6 7 →